Dogs can detect seizures by smell according to study

A group of scientific researchers from France claim they have proven that can are capable of using smell to detect epileptic seizures.

The team of researchers out of the University of Rennes are hoping that their results will lead to new methods of seizure detection.

These new methods may include dogs or even “electronic noses” which would be designed to identify the distinct scents given off during a seizure.

41% of Irish people believe the myth that you should put something in a person’s mouth to stop a seizure

41% of Irish people still incorrectly believe that you should put something in a person’s mouth during a seizure to prevent them from swallowing their tongue. The survey, to mark Purple Day (March 26th), was conducted in March 2019 by Amárach Research who asked 1,000 respondents to identify which actions they would take if they saw someone having a seizure. This figure was previously 47% when a similar survey was carried out in 2015.

Using epilepsy drug valproate during pregnancy connected to ADHD

A new study has suggested that when women use Valproate during pregnancy, the odds that her baby will develop ADHD are higher.

This report that was conducted in Denmark however cannot prove that valproate causes ADHD only that there is an association between the two.

However, this study found that fetal exposure to valproate was tied to 48% higher odds of a child developing ADHD, according to the research team which was led by Jakob Christensen at Aarhus University.

Trinity group describe the first model of mitochondrial epilepsy

A Trinity College research group have made a revelation in epilepsy research by becoming the first group to describe a model of mitochondrial epilepsy. This raises the possibility of more effective therapies being developed in the future. The paper which outlines these findings was published in BRAIN, a peer reviewed journal of neurology.

Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory Epilepsy

Medtronic plc recently announced both the U.S. launch of Deep Brain Stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted patient at Emory University in Atlanta, Ga. According to the Epilepsy Foundation, as many as 3.4 million Americans have epilepsy, with one-third estimated to be drug resistant.